December 09

Quant Snapshot: Jemtec (TSXV: JTC)

Underlying Data

1. Price to sales: 0.58

As of Q2 2009 Jemtec Inc. had 2.4 million shares outstanding.
The price as of May 29th, 2009 was C$0.70 This gives The Company a
market capitalization of $1.68 million. In the trailing four quarters,
sales totaled $2.92 million

2. Cash to Market Cap: 233%

As of Q2 2009 reported cash and short term investments were $3.88 million.

3. Debt to market Cap: $0

As of Q2 2009 reported long term debt was $100,000.

4. Trailing Three year growth rate: 7.1%

Sales were $2.59 million  in 2005. Sales grew to
$3.17 million  in 2008.

5. Enterprise Value to Sales: Zero

Enterprise Value as of May 29, 2009 is $-2.2 million, based on a market
cap of $1.68 million plus zero long term debt, minus cash
and short term investments of of $3.88 million. Sales for the trailing four quarters totaled $2.92 million.

All financial information about Jemtec Inc. is gleaned from
their filings with the System for Electronic Document Analysis and
Retrieval (SEDAR)
All calculations are based on The Company’s closing share price as of
close May 29, 2009: $.70
Sales from trailing four quarters: $2.92 million
Cash and short term investments as of June 30, 2009 (3rd Quarter)
: $3.88 million
Shares outstanding: 2.4  million.

SuperUser

Recent Posts

Has Canadian unemployment peaked?

Canada’s labour market has softened sharply since the start of the year, with the unemployment rate reaching 7% in May,… [Read More]

13 hours ago

MDA wins huge price target raise at RBC

Count RBC Capital Markets analyst Ken Herbert among the believers in MDA (MDA Stock Quote, Chart, News, Analysts, Financials TSX:MDA).… [Read More]

13 hours ago

Netlist stock is a buy, Roth says

Roth Capital Markets analyst Suji Desilva said in a July 3 report that Netlist (Netlist Stock Quote, Chart, News, Analysts,… [Read More]

13 hours ago

Theratechnologies shareholders should take the deal, Research Capital says

Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares… [Read More]

1 day ago

Haywood raises price target on KITS Eyecare to $21.00

Haywood Capital Markets analyst Gianluca Tucci reiterated a “Buy” rating on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts,… [Read More]

2 days ago

QBTS stock is still undervalued, this analyst says

Roth Capital Markets analyst Suji Desilva maintained a “Buy” rating and US$18.00 target on D-Wave Quantum (D-Wave Quantum Stock Quote,… [Read More]

2 days ago